GO:0032991 | protein-containing complex | 27.95% (45/161) | 2.59 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 51.55% (83/161) | 1.37 | 0.0 | 0.0 |
GO:1902494 | catalytic complex | 14.29% (23/161) | 3.12 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 16.15% (26/161) | 2.73 | 0.0 | 0.0 |
GO:0009987 | cellular process | 44.1% (71/161) | 1.26 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 34.16% (55/161) | 1.5 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 22.36% (36/161) | 2.06 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 39.75% (64/161) | 1.31 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 31.68% (51/161) | 1.54 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 11.18% (18/161) | 3.21 | 0.0 | 0.0 |
GO:0043226 | organelle | 26.71% (43/161) | 1.71 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 26.71% (43/161) | 1.71 | 0.0 | 0.0 |
GO:0140535 | intracellular protein-containing complex | 9.94% (16/161) | 3.47 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 40.99% (66/161) | 1.21 | 0.0 | 0.0 |
GO:0140513 | nuclear protein-containing complex | 11.8% (19/161) | 2.98 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 37.27% (60/161) | 1.29 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 19.25% (31/161) | 2.03 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 35.4% (57/161) | 1.3 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 10.56% (17/161) | 3.08 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 10.56% (17/161) | 3.08 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 31.06% (50/161) | 1.41 | 0.0 | 0.0 |
GO:0008150 | biological_process | 52.17% (84/161) | 0.91 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 13.04% (21/161) | 2.57 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 19.25% (31/161) | 1.94 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 19.25% (31/161) | 1.9 | 0.0 | 0.0 |
GO:0016071 | mRNA metabolic process | 7.45% (12/161) | 3.69 | 0.0 | 0.0 |
GO:0009057 | macromolecule catabolic process | 8.7% (14/161) | 3.27 | 0.0 | 0.0 |
GO:0005839 | proteasome core complex | 3.11% (5/161) | 7.12 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 19.25% (31/161) | 1.86 | 0.0 | 0.0 |
GO:0045948 | positive regulation of translational initiation | 1.86% (3/161) | 10.64 | 0.0 | 0.0 |
GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.86% (3/161) | 10.64 | 0.0 | 0.0 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.86% (3/161) | 10.64 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 16.15% (26/161) | 2.01 | 0.0 | 0.0 |
GO:1990904 | ribonucleoprotein complex | 8.07% (13/161) | 3.23 | 0.0 | 0.0 |
GO:1901575 | organic substance catabolic process | 10.56% (17/161) | 2.61 | 0.0 | 0.0 |
GO:0009056 | catabolic process | 10.56% (17/161) | 2.54 | 0.0 | 0.0 |
GO:0008380 | RNA splicing | 4.97% (8/161) | 4.23 | 0.0 | 0.0 |
GO:0006446 | regulation of translational initiation | 1.86% (3/161) | 8.99 | 0.0 | 1e-06 |
GO:0000398 | mRNA splicing, via spliceosome | 4.35% (7/161) | 4.46 | 0.0 | 1e-06 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 4.35% (7/161) | 4.38 | 0.0 | 1e-06 |
GO:0010498 | proteasomal protein catabolic process | 4.97% (8/161) | 3.93 | 0.0 | 2e-06 |
GO:0000375 | RNA splicing, via transesterification reactions | 4.35% (7/161) | 4.27 | 0.0 | 2e-06 |
GO:0034660 | ncRNA metabolic process | 7.45% (12/161) | 2.89 | 0.0 | 2e-06 |
GO:0051603 | proteolysis involved in protein catabolic process | 6.21% (10/161) | 3.29 | 0.0 | 2e-06 |
GO:0030163 | protein catabolic process | 4.97% (8/161) | 3.81 | 0.0 | 3e-06 |
GO:0009059 | macromolecule biosynthetic process | 8.07% (13/161) | 2.68 | 0.0 | 3e-06 |
GO:0005681 | spliceosomal complex | 4.35% (7/161) | 4.12 | 0.0 | 4e-06 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 8.7% (14/161) | 2.52 | 0.0 | 4e-06 |
GO:0034470 | ncRNA processing | 6.21% (10/161) | 3.11 | 0.0 | 6e-06 |
GO:1901565 | organonitrogen compound catabolic process | 6.21% (10/161) | 3.02 | 1e-06 | 1e-05 |
GO:1901564 | organonitrogen compound metabolic process | 20.5% (33/161) | 1.31 | 1e-06 | 1.8e-05 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 1.86% (3/161) | 7.3 | 1e-06 | 1.8e-05 |
GO:0005488 | binding | 39.13% (63/161) | 0.79 | 2e-06 | 2.8e-05 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 3.11% (5/161) | 4.68 | 2e-06 | 3e-05 |
GO:0005730 | nucleolus | 4.35% (7/161) | 3.64 | 2e-06 | 3e-05 |
GO:0006397 | mRNA processing | 4.35% (7/161) | 3.62 | 2e-06 | 3.3e-05 |
GO:0003676 | nucleic acid binding | 17.39% (28/161) | 1.4 | 2e-06 | 3.4e-05 |
GO:0043632 | modification-dependent macromolecule catabolic process | 4.97% (8/161) | 3.25 | 2e-06 | 3.7e-05 |
GO:0005665 | RNA polymerase II, core complex | 2.48% (4/161) | 5.4 | 3e-06 | 4.3e-05 |
GO:0003727 | single-stranded RNA binding | 2.48% (4/161) | 5.39 | 3e-06 | 4.4e-05 |
GO:1990234 | transferase complex | 6.21% (10/161) | 2.74 | 3e-06 | 4.5e-05 |
GO:0005840 | ribosome | 3.73% (6/161) | 3.91 | 4e-06 | 5.1e-05 |
GO:0000428 | DNA-directed RNA polymerase complex | 3.11% (5/161) | 4.46 | 4e-06 | 5.3e-05 |
GO:0006364 | rRNA processing | 4.35% (7/161) | 3.48 | 4e-06 | 5.3e-05 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 3.11% (5/161) | 4.4 | 5e-06 | 6.3e-05 |
GO:0031369 | translation initiation factor binding | 1.86% (3/161) | 6.47 | 6e-06 | 7.8e-05 |
GO:0016072 | rRNA metabolic process | 4.35% (7/161) | 3.36 | 7e-06 | 8.5e-05 |
GO:0044249 | cellular biosynthetic process | 10.56% (17/161) | 1.81 | 9e-06 | 0.000109 |
GO:0030880 | RNA polymerase complex | 3.11% (5/161) | 4.2 | 9e-06 | 0.000117 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 4.35% (7/161) | 3.26 | 1.1e-05 | 0.000129 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 5.59% (9/161) | 2.71 | 1.2e-05 | 0.000148 |
GO:0005686 | U2 snRNP | 1.86% (3/161) | 6.09 | 1.3e-05 | 0.000157 |
GO:0006402 | mRNA catabolic process | 3.11% (5/161) | 4.09 | 1.3e-05 | 0.000158 |
GO:0019538 | protein metabolic process | 16.15% (26/161) | 1.31 | 1.6e-05 | 0.000188 |
GO:0022618 | protein-RNA complex assembly | 3.11% (5/161) | 3.99 | 1.8e-05 | 0.00021 |
GO:0003674 | molecular_function | 51.55% (83/161) | 0.54 | 1.9e-05 | 0.000211 |
GO:0019941 | modification-dependent protein catabolic process | 4.35% (7/161) | 3.12 | 1.9e-05 | 0.000215 |
GO:0071826 | protein-RNA complex organization | 3.11% (5/161) | 3.95 | 2.1e-05 | 0.000233 |
GO:0006508 | proteolysis | 6.83% (11/161) | 2.27 | 2.2e-05 | 0.000237 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.48% (4/161) | 4.63 | 2.4e-05 | 0.000255 |
GO:0035770 | ribonucleoprotein granule | 2.48% (4/161) | 4.61 | 2.5e-05 | 0.000263 |
GO:1901576 | organic substance biosynthetic process | 10.56% (17/161) | 1.69 | 2.5e-05 | 0.000264 |
GO:0006401 | RNA catabolic process | 3.11% (5/161) | 3.84 | 3e-05 | 0.00031 |
GO:0009058 | biosynthetic process | 10.56% (17/161) | 1.61 | 4.7e-05 | 0.000484 |
GO:0045727 | positive regulation of translation | 1.86% (3/161) | 5.42 | 5.3e-05 | 0.000519 |
GO:0034250 | positive regulation of amide metabolic process | 1.86% (3/161) | 5.42 | 5.3e-05 | 0.000519 |
GO:0071011 | precatalytic spliceosome | 1.86% (3/161) | 5.42 | 5.3e-05 | 0.000519 |
GO:0031331 | positive regulation of cellular catabolic process | 1.86% (3/161) | 5.38 | 5.7e-05 | 0.000536 |
GO:0061014 | positive regulation of mRNA catabolic process | 1.86% (3/161) | 5.38 | 5.7e-05 | 0.000536 |
GO:0034655 | nucleobase-containing compound catabolic process | 3.73% (6/161) | 3.21 | 5.5e-05 | 0.000538 |
GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic | 1.86% (3/161) | 5.39 | 5.6e-05 | 0.000542 |
GO:0043231 | intracellular membrane-bounded organelle | 16.15% (26/161) | 1.2 | 5.9e-05 | 0.000555 |
GO:0006367 | transcription initiation at RNA polymerase II promoter | 1.86% (3/161) | 5.34 | 6.3e-05 | 0.000579 |
GO:0051641 | cellular localization | 6.21% (10/161) | 2.23 | 6.6e-05 | 0.0006 |
GO:0043227 | membrane-bounded organelle | 16.15% (26/161) | 1.19 | 6.7e-05 | 0.000608 |
GO:0045184 | establishment of protein localization | 4.97% (8/161) | 2.57 | 7.2e-05 | 0.000647 |
GO:0061013 | regulation of mRNA catabolic process | 1.86% (3/161) | 5.2 | 8.2e-05 | 0.00073 |
GO:0018130 | heterocycle biosynthetic process | 5.59% (9/161) | 2.35 | 8.3e-05 | 0.00073 |
GO:0044270 | cellular nitrogen compound catabolic process | 3.73% (6/161) | 3.08 | 8.8e-05 | 0.000759 |
GO:0046700 | heterocycle catabolic process | 3.73% (6/161) | 3.08 | 8.8e-05 | 0.000759 |
GO:0071840 | cellular component organization or biogenesis | 9.32% (15/161) | 1.66 | 9.5e-05 | 0.00081 |
GO:0032774 | RNA biosynthetic process | 3.73% (6/161) | 3.02 | 0.000114 | 0.000957 |
GO:0003735 | structural constituent of ribosome | 3.11% (5/161) | 3.42 | 0.000119 | 0.000991 |
GO:0019438 | aromatic compound biosynthetic process | 5.59% (9/161) | 2.27 | 0.000121 | 0.001003 |
GO:0046039 | GTP metabolic process | 1.24% (2/161) | 6.91 | 0.000133 | 0.001062 |
GO:0006183 | GTP biosynthetic process | 1.24% (2/161) | 6.91 | 0.000133 | 0.001062 |
GO:1903313 | positive regulation of mRNA metabolic process | 1.86% (3/161) | 4.98 | 0.000131 | 0.001064 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 3.11% (5/161) | 3.39 | 0.000131 | 0.001072 |
GO:0005198 | structural molecule activity | 3.73% (6/161) | 2.96 | 0.000138 | 0.001091 |
GO:0008135 | translation factor activity, RNA binding | 2.48% (4/161) | 3.95 | 0.000146 | 0.001133 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2.48% (4/161) | 3.95 | 0.000146 | 0.001133 |
GO:0008104 | protein localization | 4.97% (8/161) | 2.41 | 0.000152 | 0.001162 |
GO:0006414 | translational elongation | 1.86% (3/161) | 4.89 | 0.000157 | 0.001169 |
GO:0070727 | cellular macromolecule localization | 4.97% (8/161) | 2.41 | 0.000154 | 0.00117 |
GO:0033036 | macromolecule localization | 4.97% (8/161) | 2.41 | 0.000156 | 0.001175 |
GO:0005687 | U4 snRNP | 1.24% (2/161) | 6.78 | 0.000161 | 0.001189 |
GO:0019439 | aromatic compound catabolic process | 3.73% (6/161) | 2.91 | 0.000167 | 0.001225 |
GO:0010628 | positive regulation of gene expression | 1.86% (3/161) | 4.81 | 0.000183 | 0.001313 |
GO:1901361 | organic cyclic compound catabolic process | 3.73% (6/161) | 2.89 | 0.000183 | 0.001322 |
GO:0006399 | tRNA metabolic process | 3.73% (6/161) | 2.89 | 0.000182 | 0.001326 |
GO:0006351 | DNA-templated transcription | 3.11% (5/161) | 3.27 | 0.000195 | 0.001382 |
GO:0006412 | translation | 3.11% (5/161) | 3.24 | 0.00021 | 0.001478 |
GO:0045182 | translation regulator activity | 2.48% (4/161) | 3.77 | 0.000235 | 0.00164 |
GO:1901362 | organic cyclic compound biosynthetic process | 5.59% (9/161) | 2.12 | 0.000259 | 0.001797 |
GO:0045335 | phagocytic vesicle | 0.62% (1/161) | 11.87 | 0.000268 | 0.001827 |
GO:0090385 | phagosome-lysosome fusion | 0.62% (1/161) | 11.87 | 0.000268 | 0.001827 |
GO:0044248 | cellular catabolic process | 4.97% (8/161) | 2.28 | 0.000279 | 0.001869 |
GO:0031327 | negative regulation of cellular biosynthetic process | 3.73% (6/161) | 2.78 | 0.000278 | 0.00188 |
GO:0009890 | negative regulation of biosynthetic process | 3.73% (6/161) | 2.77 | 0.000284 | 0.001894 |
GO:0097159 | organic cyclic compound binding | 24.84% (40/161) | 0.79 | 0.000304 | 0.002008 |
GO:0043043 | peptide biosynthetic process | 3.11% (5/161) | 3.12 | 0.000311 | 0.002026 |
GO:0072594 | establishment of protein localization to organelle | 3.11% (5/161) | 3.12 | 0.000311 | 0.002038 |
GO:0048523 | negative regulation of cellular process | 4.35% (7/161) | 2.46 | 0.000321 | 0.002072 |
GO:0005682 | U5 snRNP | 1.24% (2/161) | 6.25 | 0.000333 | 0.002121 |
GO:0097428 | protein maturation by iron-sulfur cluster transfer | 1.24% (2/161) | 6.25 | 0.000333 | 0.002121 |
GO:0019843 | rRNA binding | 1.86% (3/161) | 4.49 | 0.000348 | 0.0022 |
GO:0048519 | negative regulation of biological process | 4.35% (7/161) | 2.44 | 0.000357 | 0.002236 |
GO:0022607 | cellular component assembly | 4.35% (7/161) | 2.43 | 0.000361 | 0.002247 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 3.11% (5/161) | 3.07 | 0.000367 | 0.002267 |
GO:0043233 | organelle lumen | 1.86% (3/161) | 4.44 | 0.000391 | 0.002363 |
GO:0031974 | membrane-enclosed lumen | 1.86% (3/161) | 4.44 | 0.000391 | 0.002363 |
GO:0070013 | intracellular organelle lumen | 1.86% (3/161) | 4.44 | 0.000391 | 0.002363 |
GO:0071013 | catalytic step 2 spliceosome | 1.86% (3/161) | 4.41 | 0.000415 | 0.002494 |
GO:0000932 | P-body | 1.86% (3/161) | 4.38 | 0.000436 | 0.002602 |
GO:0033365 | protein localization to organelle | 3.11% (5/161) | 3.0 | 0.000445 | 0.002634 |
GO:0097602 | cullin family protein binding | 1.24% (2/161) | 6.02 | 0.000458 | 0.002697 |
GO:1903311 | regulation of mRNA metabolic process | 1.86% (3/161) | 4.33 | 0.00048 | 0.002804 |
GO:0031324 | negative regulation of cellular metabolic process | 3.73% (6/161) | 2.62 | 0.000489 | 0.002836 |
GO:0030532 | small nuclear ribonucleoprotein complex | 1.86% (3/161) | 4.32 | 0.000498 | 0.00285 |
GO:0097525 | spliceosomal snRNP complex | 1.86% (3/161) | 4.32 | 0.000495 | 0.002854 |
GO:0009892 | negative regulation of metabolic process | 3.73% (6/161) | 2.61 | 0.000503 | 0.00286 |
GO:0071705 | nitrogen compound transport | 4.97% (8/161) | 2.14 | 0.000524 | 0.002959 |
GO:0005829 | cytosol | 5.59% (9/161) | 1.98 | 0.000537 | 0.003015 |
GO:0010629 | negative regulation of gene expression | 3.11% (5/161) | 2.92 | 0.000581 | 0.003242 |
GO:0120114 | Sm-like protein family complex | 1.86% (3/161) | 4.18 | 0.000652 | 0.003612 |
GO:0031329 | regulation of cellular catabolic process | 1.86% (3/161) | 4.17 | 0.00067 | 0.00369 |
GO:0006518 | peptide metabolic process | 3.11% (5/161) | 2.86 | 0.000692 | 0.003784 |
GO:0043933 | protein-containing complex organization | 4.35% (7/161) | 2.27 | 0.000704 | 0.003825 |
GO:0006352 | DNA-templated transcription initiation | 1.86% (3/161) | 4.11 | 0.000757 | 0.004066 |
GO:0022625 | cytosolic large ribosomal subunit | 1.86% (3/161) | 4.11 | 0.000754 | 0.004073 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.86% (3/161) | 4.1 | 0.000764 | 0.004076 |
GO:0015031 | protein transport | 3.73% (6/161) | 2.46 | 0.00086 | 0.004559 |
GO:0009896 | positive regulation of catabolic process | 1.86% (3/161) | 4.0 | 0.000929 | 0.004897 |
GO:1901566 | organonitrogen compound biosynthetic process | 4.97% (8/161) | 2.0 | 0.000991 | 0.005189 |
GO:0043604 | amide biosynthetic process | 3.11% (5/161) | 2.73 | 0.001052 | 0.005477 |
GO:0000387 | spliceosomal snRNP assembly | 1.24% (2/161) | 5.38 | 0.001102 | 0.0057 |
GO:0006163 | purine nucleotide metabolic process | 3.11% (5/161) | 2.66 | 0.001272 | 0.006545 |
GO:0016043 | cellular component organization | 7.45% (12/161) | 1.49 | 0.001287 | 0.006578 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.24% (2/161) | 5.25 | 0.001317 | 0.006696 |
GO:0015934 | large ribosomal subunit | 1.86% (3/161) | 3.82 | 0.001329 | 0.006714 |
GO:0032447 | protein urmylation | 0.62% (1/161) | 9.54 | 0.001339 | 0.006726 |
GO:0005685 | U1 snRNP | 1.24% (2/161) | 5.18 | 0.001453 | 0.007257 |
GO:0051604 | protein maturation | 1.86% (3/161) | 3.74 | 0.001555 | 0.007722 |
GO:0043066 | negative regulation of apoptotic process | 0.62% (1/161) | 9.28 | 0.001606 | 0.007931 |
GO:0072521 | purine-containing compound metabolic process | 3.11% (5/161) | 2.57 | 0.001668 | 0.008188 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 3.11% (5/161) | 2.55 | 0.00177 | 0.008637 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 1.24% (2/161) | 5.02 | 0.001805 | 0.008709 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 1.24% (2/161) | 5.02 | 0.001805 | 0.008709 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.86% (3/161) | 3.64 | 0.001893 | 0.009084 |
GO:0006417 | regulation of translation | 1.86% (3/161) | 3.63 | 0.001929 | 0.009154 |
GO:0034248 | regulation of amide metabolic process | 1.86% (3/161) | 3.63 | 0.001929 | 0.009154 |
GO:0065003 | protein-containing complex assembly | 3.11% (5/161) | 2.52 | 0.001947 | 0.009188 |
GO:0097526 | spliceosomal tri-snRNP complex | 1.24% (2/161) | 4.96 | 0.001962 | 0.009209 |
GO:0045721 | negative regulation of gluconeogenesis | 0.62% (1/161) | 8.87 | 0.002141 | 0.009681 |
GO:0006111 | regulation of gluconeogenesis | 0.62% (1/161) | 8.87 | 0.002141 | 0.009681 |
GO:0007039 | protein catabolic process in the vacuole | 0.62% (1/161) | 8.87 | 0.002141 | 0.009681 |
GO:0034367 | protein-containing complex remodeling | 0.62% (1/161) | 8.87 | 0.002141 | 0.009681 |
GO:0001112 | DNA-templated transcription open complex formation | 0.62% (1/161) | 8.87 | 0.002141 | 0.009681 |
GO:0001120 | protein-DNA complex remodeling | 0.62% (1/161) | 8.87 | 0.002141 | 0.009681 |
GO:0001113 | transcription open complex formation at RNA polymerase II promoter | 0.62% (1/161) | 8.87 | 0.002141 | 0.009681 |
GO:0071702 | organic substance transport | 4.97% (8/161) | 1.82 | 0.002193 | 0.009863 |
GO:0003746 | translation elongation factor activity | 1.24% (2/161) | 4.85 | 0.002261 | 0.010115 |
GO:0099080 | supramolecular complex | 2.48% (4/161) | 2.88 | 0.002316 | 0.010308 |
GO:0051247 | positive regulation of protein metabolic process | 1.86% (3/161) | 3.52 | 0.002423 | 0.010729 |
GO:0003924 | GTPase activity | 2.48% (4/161) | 2.84 | 0.002526 | 0.011073 |
GO:0005666 | RNA polymerase III complex | 1.24% (2/161) | 4.77 | 0.002525 | 0.011124 |
GO:0019637 | organophosphate metabolic process | 4.35% (7/161) | 1.94 | 0.002613 | 0.011396 |
GO:0016578 | histone deubiquitination | 0.62% (1/161) | 8.54 | 0.002676 | 0.011551 |
GO:0019774 | proteasome core complex, beta-subunit complex | 0.62% (1/161) | 8.54 | 0.002676 | 0.011551 |
GO:0009117 | nucleotide metabolic process | 3.11% (5/161) | 2.41 | 0.002694 | 0.011571 |
GO:0141047 | molecular tag activity | 1.24% (2/161) | 4.7 | 0.002784 | 0.011841 |
GO:0031386 | protein tag activity | 1.24% (2/161) | 4.7 | 0.002784 | 0.011841 |
GO:0006753 | nucleoside phosphate metabolic process | 3.11% (5/161) | 2.4 | 0.002814 | 0.011907 |
GO:0042273 | ribosomal large subunit biogenesis | 1.24% (2/161) | 4.69 | 0.002842 | 0.011965 |
GO:0032561 | guanyl ribonucleotide binding | 2.48% (4/161) | 2.78 | 0.002933 | 0.012229 |
GO:0005525 | GTP binding | 2.48% (4/161) | 2.78 | 0.002933 | 0.012229 |
GO:0010605 | negative regulation of macromolecule metabolic process | 3.11% (5/161) | 2.38 | 0.002958 | 0.012276 |
GO:0016226 | iron-sulfur cluster assembly | 1.24% (2/161) | 4.62 | 0.003095 | 0.012723 |
GO:0031163 | metallo-sulfur cluster assembly | 1.24% (2/161) | 4.62 | 0.003095 | 0.012723 |
GO:0071819 | DUBm complex | 0.62% (1/161) | 8.28 | 0.00321 | 0.013069 |
GO:0005853 | eukaryotic translation elongation factor 1 complex | 0.62% (1/161) | 8.28 | 0.00321 | 0.013069 |
GO:0098798 | mitochondrial protein-containing complex | 1.86% (3/161) | 3.36 | 0.003275 | 0.013146 |
GO:0006400 | tRNA modification | 1.86% (3/161) | 3.36 | 0.003275 | 0.013146 |
GO:0051254 | positive regulation of RNA metabolic process | 2.48% (4/161) | 2.73 | 0.003298 | 0.013175 |
GO:0019001 | guanyl nucleotide binding | 2.48% (4/161) | 2.74 | 0.003261 | 0.013214 |
GO:0000027 | ribosomal large subunit assembly | 1.24% (2/161) | 4.56 | 0.00338 | 0.013443 |
GO:0009150 | purine ribonucleotide metabolic process | 2.48% (4/161) | 2.72 | 0.003419 | 0.013533 |
GO:0022904 | respiratory electron transport chain | 1.24% (2/161) | 4.5 | 0.003634 | 0.014061 |
GO:0006091 | generation of precursor metabolites and energy | 2.48% (4/161) | 2.7 | 0.003576 | 0.014089 |
GO:0031328 | positive regulation of cellular biosynthetic process | 2.48% (4/161) | 2.69 | 0.003631 | 0.014112 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 2.48% (4/161) | 2.69 | 0.003631 | 0.014112 |
GO:0009891 | positive regulation of biosynthetic process | 2.48% (4/161) | 2.69 | 0.003631 | 0.014112 |
GO:0043603 | amide metabolic process | 3.11% (5/161) | 2.3 | 0.003704 | 0.014268 |
GO:0006164 | purine nucleotide biosynthetic process | 1.86% (3/161) | 3.28 | 0.003849 | 0.014759 |
GO:0009894 | regulation of catabolic process | 1.86% (3/161) | 3.27 | 0.003886 | 0.01477 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1.86% (3/161) | 3.27 | 0.003877 | 0.0148 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 1.86% (3/161) | 3.26 | 0.004008 | 0.015101 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 2.48% (4/161) | 2.65 | 0.004004 | 0.015151 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | 1.24% (2/161) | 4.41 | 0.004144 | 0.015409 |
GO:0098803 | respiratory chain complex | 1.24% (2/161) | 4.41 | 0.004144 | 0.015409 |
GO:0003713 | transcription coactivator activity | 1.24% (2/161) | 4.41 | 0.004121 | 0.015458 |
GO:0042788 | polysomal ribosome | 0.62% (1/161) | 7.87 | 0.004278 | 0.015705 |
GO:0045046 | protein import into peroxisome membrane | 0.62% (1/161) | 7.87 | 0.004278 | 0.015705 |
GO:0000470 | maturation of LSU-rRNA | 1.24% (2/161) | 4.39 | 0.004259 | 0.015769 |
GO:0003697 | single-stranded DNA binding | 1.86% (3/161) | 3.2 | 0.00447 | 0.016339 |
GO:0009260 | ribonucleotide biosynthetic process | 1.86% (3/161) | 3.18 | 0.004676 | 0.017018 |
GO:0072522 | purine-containing compound biosynthetic process | 1.86% (3/161) | 3.17 | 0.00476 | 0.017251 |
GO:0003938 | IMP dehydrogenase activity | 0.62% (1/161) | 7.7 | 0.004812 | 0.017294 |
GO:0030122 | AP-2 adaptor complex | 0.62% (1/161) | 7.7 | 0.004812 | 0.017294 |
GO:0005759 | mitochondrial matrix | 1.24% (2/161) | 4.28 | 0.004905 | 0.017556 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 1.24% (2/161) | 4.27 | 0.00498 | 0.017749 |
GO:0034719 | SMN-Sm protein complex | 0.62% (1/161) | 7.62 | 0.005078 | 0.017878 |
GO:0070037 | rRNA (pseudouridine) methyltransferase activity | 0.62% (1/161) | 7.62 | 0.005078 | 0.017878 |
GO:0008023 | transcription elongation factor complex | 1.24% (2/161) | 4.26 | 0.005054 | 0.017941 |
GO:0046390 | ribose phosphate biosynthetic process | 1.86% (3/161) | 3.13 | 0.005148 | 0.018051 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3.11% (5/161) | 2.19 | 0.005208 | 0.018185 |
GO:0044391 | ribosomal subunit | 1.86% (3/161) | 3.09 | 0.005521 | 0.019201 |
GO:0043186 | P granule | 0.62% (1/161) | 7.47 | 0.005611 | 0.01928 |
GO:0042981 | regulation of apoptotic process | 0.62% (1/161) | 7.47 | 0.005611 | 0.01928 |
GO:0009259 | ribonucleotide metabolic process | 2.48% (4/161) | 2.51 | 0.005598 | 0.019389 |
GO:0098796 | membrane protein complex | 3.11% (5/161) | 2.15 | 0.00574 | 0.019646 |
GO:0045912 | negative regulation of carbohydrate metabolic process | 0.62% (1/161) | 7.41 | 0.005878 | 0.019723 |
GO:0009013 | succinate-semialdehyde dehydrogenase [NAD(P)+] activity | 0.62% (1/161) | 7.41 | 0.005878 | 0.019723 |
GO:0004777 | succinate-semialdehyde dehydrogenase (NAD+) activity | 0.62% (1/161) | 7.41 | 0.005878 | 0.019723 |
GO:0004452 | isopentenyl-diphosphate delta-isomerase activity | 0.62% (1/161) | 7.41 | 0.005878 | 0.019723 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 1.86% (3/161) | 3.05 | 0.00591 | 0.019752 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 1.24% (2/161) | 4.13 | 0.005994 | 0.019957 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 1.24% (2/161) | 4.15 | 0.005859 | 0.019972 |
GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process | 0.62% (1/161) | 7.34 | 0.006144 | 0.020299 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 0.62% (1/161) | 7.34 | 0.006144 | 0.020299 |
GO:0005737 | cytoplasm | 7.45% (12/161) | 1.21 | 0.00624 | 0.020537 |
GO:0009141 | nucleoside triphosphate metabolic process | 1.86% (3/161) | 3.01 | 0.006415 | 0.020872 |
GO:0019693 | ribose phosphate metabolic process | 2.48% (4/161) | 2.46 | 0.006447 | 0.0209 |
GO:0005673 | transcription factor TFIIE complex | 0.62% (1/161) | 7.28 | 0.00641 | 0.020937 |
GO:0000408 | EKC/KEOPS complex | 0.62% (1/161) | 7.28 | 0.00641 | 0.020937 |
GO:0008033 | tRNA processing | 1.86% (3/161) | 3.0 | 0.00658 | 0.021249 |
GO:0005854 | nascent polypeptide-associated complex | 0.62% (1/161) | 7.22 | 0.006677 | 0.0214 |
GO:0034657 | GID complex | 0.62% (1/161) | 7.22 | 0.006677 | 0.0214 |
GO:0005783 | endoplasmic reticulum | 2.48% (4/161) | 2.42 | 0.006958 | 0.02222 |
GO:0006413 | translational initiation | 1.24% (2/161) | 4.01 | 0.007065 | 0.022479 |
GO:0005634 | nucleus | 8.07% (13/161) | 1.13 | 0.007133 | 0.022609 |
GO:0043069 | negative regulation of programmed cell death | 0.62% (1/161) | 7.06 | 0.007475 | 0.023606 |
GO:0046923 | ER retention sequence binding | 0.62% (1/161) | 7.01 | 0.007741 | 0.024179 |
GO:0043953 | protein transport by the Tat complex | 0.62% (1/161) | 7.01 | 0.007741 | 0.024179 |
GO:0031325 | positive regulation of cellular metabolic process | 2.48% (4/161) | 2.38 | 0.007686 | 0.024185 |
GO:0090114 | COPII-coated vesicle budding | 0.62% (1/161) | 6.96 | 0.008007 | 0.02474 |
GO:0098799 | outer mitochondrial membrane protein complex | 0.62% (1/161) | 6.96 | 0.008007 | 0.02474 |
GO:0005742 | mitochondrial outer membrane translocase complex | 0.62% (1/161) | 6.96 | 0.008007 | 0.02474 |
GO:0008379 | thioredoxin peroxidase activity | 0.62% (1/161) | 6.87 | 0.008538 | 0.026194 |
GO:0140824 | thioredoxin-dependent peroxiredoxin activity | 0.62% (1/161) | 6.87 | 0.008538 | 0.026194 |
GO:0005758 | mitochondrial intermembrane space | 0.62% (1/161) | 6.82 | 0.008804 | 0.026817 |
GO:0031970 | organelle envelope lumen | 0.62% (1/161) | 6.82 | 0.008804 | 0.026817 |
GO:0030433 | ubiquitin-dependent ERAD pathway | 1.24% (2/161) | 3.82 | 0.009082 | 0.027471 |
GO:0004298 | threonine-type endopeptidase activity | 0.62% (1/161) | 6.78 | 0.009069 | 0.027528 |
GO:0051920 | peroxiredoxin activity | 0.62% (1/161) | 6.74 | 0.009335 | 0.028037 |
GO:0010906 | regulation of glucose metabolic process | 0.62% (1/161) | 6.74 | 0.009335 | 0.028037 |
GO:0000151 | ubiquitin ligase complex | 1.86% (3/161) | 2.8 | 0.009494 | 0.028417 |
GO:0030139 | endocytic vesicle | 0.62% (1/161) | 6.7 | 0.0096 | 0.028634 |
GO:0051234 | establishment of localization | 8.07% (13/161) | 1.06 | 0.010415 | 0.030958 |
GO:0071806 | protein transmembrane transport | 1.24% (2/161) | 3.7 | 0.010682 | 0.03164 |
GO:0016192 | vesicle-mediated transport | 3.11% (5/161) | 1.92 | 0.0109 | 0.032175 |
GO:0009165 | nucleotide biosynthetic process | 1.86% (3/161) | 2.72 | 0.011026 | 0.032324 |
GO:1901293 | nucleoside phosphate biosynthetic process | 1.86% (3/161) | 2.72 | 0.011026 | 0.032324 |
GO:0004641 | phosphoribosylformylglycinamidine cyclo-ligase activity | 0.62% (1/161) | 6.47 | 0.011191 | 0.032698 |
GO:0045257 | succinate dehydrogenase complex (ubiquinone) | 0.62% (1/161) | 6.44 | 0.011456 | 0.033134 |
GO:0045283 | fumarate reductase complex | 0.62% (1/161) | 6.44 | 0.011456 | 0.033134 |
GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) | 0.62% (1/161) | 6.44 | 0.011456 | 0.033134 |
GO:0006228 | UTP biosynthetic process | 0.62% (1/161) | 6.41 | 0.011721 | 0.03345 |
GO:0046051 | UTP metabolic process | 0.62% (1/161) | 6.41 | 0.011721 | 0.03345 |
GO:0045281 | succinate dehydrogenase complex | 0.62% (1/161) | 6.41 | 0.011721 | 0.03345 |
GO:0048522 | positive regulation of cellular process | 2.48% (4/161) | 2.21 | 0.011615 | 0.033481 |
GO:0046084 | adenine biosynthetic process | 0.62% (1/161) | 6.37 | 0.011986 | 0.033868 |
GO:0046083 | adenine metabolic process | 0.62% (1/161) | 6.37 | 0.011986 | 0.033868 |
GO:0010608 | post-transcriptional regulation of gene expression | 1.86% (3/161) | 2.67 | 0.012134 | 0.034061 |
GO:0003743 | translation initiation factor activity | 1.24% (2/161) | 3.61 | 0.011985 | 0.034089 |
GO:0036503 | ERAD pathway | 1.24% (2/161) | 3.6 | 0.012134 | 0.034173 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 2.48% (4/161) | 2.18 | 0.01225 | 0.034276 |
GO:0034227 | tRNA thio-modification | 0.62% (1/161) | 6.31 | 0.012515 | 0.034905 |
GO:0009893 | positive regulation of metabolic process | 2.48% (4/161) | 2.16 | 0.01283 | 0.035551 |
GO:0010604 | positive regulation of macromolecule metabolic process | 2.48% (4/161) | 2.16 | 0.012804 | 0.035595 |
GO:0006621 | protein retention in ER lumen | 0.62% (1/161) | 6.19 | 0.013573 | 0.03737 |
GO:0035437 | maintenance of protein localization in endoplasmic reticulum | 0.62% (1/161) | 6.19 | 0.013573 | 0.03737 |
GO:0034715 | pICln-Sm protein complex | 0.62% (1/161) | 6.17 | 0.013838 | 0.037735 |
GO:0032044 | DSIF complex | 0.62% (1/161) | 6.17 | 0.013838 | 0.037735 |
GO:0051179 | localization | 8.07% (13/161) | 1.0 | 0.013773 | 0.037797 |
GO:0043527 | tRNA methyltransferase complex | 0.62% (1/161) | 6.14 | 0.014102 | 0.038213 |
GO:0043255 | regulation of carbohydrate biosynthetic process | 0.62% (1/161) | 6.14 | 0.014102 | 0.038213 |
GO:0044085 | cellular component biogenesis | 1.86% (3/161) | 2.59 | 0.014191 | 0.038333 |
GO:0022900 | electron transport chain | 1.24% (2/161) | 3.47 | 0.014302 | 0.038512 |
GO:0030674 | protein-macromolecule adaptor activity | 1.24% (2/161) | 3.46 | 0.014584 | 0.039148 |
GO:0140673 | transcription elongation-coupled chromatin remodeling | 0.62% (1/161) | 6.08 | 0.01463 | 0.03915 |
GO:0036265 | RNA (guanine-N7)-methylation | 0.62% (1/161) | 6.03 | 0.015158 | 0.040312 |
GO:0098800 | inner mitochondrial membrane protein complex | 1.24% (2/161) | 3.43 | 0.015155 | 0.040428 |
GO:0016077 | sno(s)RNA catabolic process | 0.62% (1/161) | 5.91 | 0.016477 | 0.041751 |
GO:0071036 | nuclear polyadenylation-dependent snoRNA catabolic process | 0.62% (1/161) | 5.91 | 0.016477 | 0.041751 |
GO:0071037 | nuclear polyadenylation-dependent snRNA catabolic process | 0.62% (1/161) | 5.91 | 0.016477 | 0.041751 |
GO:0016076 | snRNA catabolic process | 0.62% (1/161) | 5.91 | 0.016477 | 0.041751 |
GO:0071039 | nuclear polyadenylation-dependent CUT catabolic process | 0.62% (1/161) | 5.91 | 0.016477 | 0.041751 |
GO:0070125 | mitochondrial translational elongation | 0.62% (1/161) | 5.91 | 0.016477 | 0.041751 |
GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen | 0.62% (1/161) | 5.96 | 0.015949 | 0.04177 |
GO:0071040 | nuclear polyadenylation-dependent antisense transcript catabolic process | 0.62% (1/161) | 5.96 | 0.015949 | 0.04177 |
GO:0042868 | antisense RNA metabolic process | 0.62% (1/161) | 5.96 | 0.015949 | 0.04177 |
GO:0071041 | antisense RNA transcript catabolic process | 0.62% (1/161) | 5.96 | 0.015949 | 0.04177 |
GO:0071044 | histone mRNA catabolic process | 0.62% (1/161) | 5.96 | 0.015949 | 0.04177 |
GO:0010243 | response to organonitrogen compound | 1.24% (2/161) | 3.38 | 0.016241 | 0.041894 |
GO:0005779 | obsolete integral component of peroxisomal membrane | 0.62% (1/161) | 5.94 | 0.016213 | 0.041949 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 0.62% (1/161) | 5.94 | 0.016213 | 0.041949 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 0.62% (1/161) | 5.94 | 0.016213 | 0.041949 |
GO:0090150 | establishment of protein localization to membrane | 1.24% (2/161) | 3.38 | 0.016198 | 0.042293 |
GO:0097708 | intracellular vesicle | 1.86% (3/161) | 2.49 | 0.016919 | 0.042619 |
GO:0031410 | cytoplasmic vesicle | 1.86% (3/161) | 2.49 | 0.016919 | 0.042619 |
GO:0035615 | clathrin adaptor activity | 0.62% (1/161) | 5.87 | 0.017004 | 0.042708 |
GO:0090407 | organophosphate biosynthetic process | 2.48% (4/161) | 2.03 | 0.017457 | 0.04372 |
GO:0045116 | protein neddylation | 0.62% (1/161) | 5.82 | 0.01753 | 0.043775 |
GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds | 0.62% (1/161) | 5.78 | 0.018057 | 0.0447 |
GO:0006624 | vacuolar protein processing | 0.62% (1/161) | 5.78 | 0.018057 | 0.0447 |
GO:0005515 | protein binding | 12.42% (20/161) | 0.73 | 0.017959 | 0.044716 |
GO:0009451 | RNA modification | 2.48% (4/161) | 2.01 | 0.018134 | 0.044761 |
GO:0006431 | methionyl-tRNA aminoacylation | 0.62% (1/161) | 5.72 | 0.018846 | 0.046253 |
GO:0004825 | methionine-tRNA ligase activity | 0.62% (1/161) | 5.72 | 0.018846 | 0.046253 |
GO:0140312 | cargo adaptor activity | 0.62% (1/161) | 5.68 | 0.019372 | 0.047408 |
GO:0070003 | threonine-type peptidase activity | 0.62% (1/161) | 5.66 | 0.019634 | 0.047915 |
GO:0051540 | metal cluster binding | 1.24% (2/161) | 3.22 | 0.019967 | 0.04845 |
GO:0051536 | iron-sulfur cluster binding | 1.24% (2/161) | 3.22 | 0.019967 | 0.04845 |
GO:1990204 | oxidoreductase complex | 1.24% (2/161) | 3.21 | 0.020059 | 0.048538 |
GO:0009448 | gamma-aminobutyric acid metabolic process | 0.62% (1/161) | 5.6 | 0.020422 | 0.049139 |
GO:0016050 | vesicle organization | 1.24% (2/161) | 3.2 | 0.020385 | 0.049188 |